References
- Gómez-Ochoa SA, Franco OH, Rojas LZ, Raguindin PF, Roa-Díaz ZM, Wyssmann BM, Guevara SLR, Echeverría LE, Glisic M, Muka T, et al. COVID-19 in health-care workers: a living systematic review and meta-analysis of prevalence, risk factors, clinical characteristics, and outcomes. Am J Epidemiol. 2021;190(1):161–75.doi:https://doi.org/10.1093/aje/kwaa191.
- Pollard CA, Morran MP, Nestor-Kalinoski AL. The covid-19 pandemic: a global health crisis. Physiol Genomics. 2020;52(11):549–57.doi:https://doi.org/10.1152/physiolgenomics.00089.2020.
- Ophinni Y, Hasibuan AS, Widhani A, Maria S. COVID-19 vaccines: current status and implication for use in Indonesia. Indones J Int Med. 2021;52(4):388–412.
- World Health Organization. 2021. Indonesia Situation (online). [Accessed 2021 Nov 29th]. https://covid19.who.int/region/searo/country/id.
- Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, Han W, Chen Z, Tang R, Yin W, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021;21(2):181–92.doi:https://doi.org/10.1016/S1473-3099(20)30843-4.
- Tanriover MD, Doğanay HL, Akova M, Güner HR, Azap A, Akhan S, et al. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. Lancet. 2021;398(10296):213–22.doi:https://doi.org/10.1016/S0140-6736(21)01429-X.
- Wu Z, Hu Y, Xu M, Chen Z, Yang W, Jiang Z, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021;21(6):803–12.doi:https://doi.org/10.1016/S1473-3099(20)30987-7.
- Sereti E, Stamatelopoulos KS, Zakopoulos NA, Evangelopoulou A, Mavragani CP, Evangelopoulos ME. Hypertension: an immune related disorder? Clin Immunol. 2020;212:108247.
- Watanabe M, Balena A, Tuccinardi D, Tozzi R, Risi R, Masi D, et al. Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID-19 mRNA vaccine. Diabetes Metab Res Rev. 2021;2021:e3465.
- Chodick G, Tene L, Rotem RS, Patalon T, Gazit S, Ben-Tov A, Weil C, Goldshtein I, Twig G, Cohen D, et al. the effectiveness of the two-dose BNT162b2 vaccine: analysis of real-world data. Clin Infect Dis. 2021;2021:ciab438.
- Peltzer K, Pengpid S. The prevalence and social determinants of hypertension among adults in Indonesia: a cross-sectional population-based national survey. Int J Hypertens. 2018;2018:5610725.doi:https://doi.org/10.1155/2018/5610725.
- Pellini R, Venuti A, Pimpinelli F, Abril E, Blandino G, Campo F, et al. Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine. EClinicalMedicine 2021;41:2058–66.
- Shibata S, Arima H, Asayama K, Hoshide S, Ichihara A, Ishimitsu T, Kario K, Kishi T, Mogi M, Nishiyama A, et al. Hypertension and related diseases in the era of COVID-19: a report from the Japanese society of hypertension task force on COVID-19. Hypertens Res. 2020;43(10):1.doi:https://doi.org/10.1038/s41440-020-0515-0.
- Lo Sasso B, Giglio RV, Vidali M, Scazzone C, Bivona G, Gambino CM, Ciaccio AM, Agnello L, Ciaccio M. Evaluation of anti-SARS-Cov-2 S-RBD IgG antibodies after COVID-19 mRNA BNT162b2 vaccine. Diagnostics (Basel). 2021 Jun 22;11(7):1135. doi: https://doi.org/10.3390/diagnostics11071135.
- Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, et al. International society of hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334–57.doi:https://doi.org/10.1161/HYPERTENSIONAHA.120.15026.
- Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al. ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104.doi:https://doi.org/10.1093/eurheartj/ehy339.
- Gavriatopoulou M, Korompoki E, Fotiou D, Ntanasis-Stathopoulos I, Psaltopoulou T, Kastritis E, Terpos E, Dimopoulos MA, et al. Organ-specific manifestations of COVID-19 infection. Clin Exp Med. 2020;20(4):493–506.doi:https://doi.org/10.1007/s10238-020-00648-x.
- National Institutes of Health. Treatment guidelines panel. Coronavirus disease 2019 (COVID-19). Nih. Internet. 2021;2019;36–38 .
- Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J, He J, et al. Global disparities of hypertension prevalence and control. Circulation. 2016;134(6):441–50.doi:https://doi.org/10.1161/CIRCULATIONAHA.115.018912.
- Bawazir LAA, Sianipar W. Treating patients with hypertension in Indonesia’s primary health care centre: a challenging condition. Glob Cardiol Sci Pract. 2019;2019(2):e201914.doi:https://doi.org/10.21542/gcsp.2019.14.
- Jara A, Undurraga EA, González C, Paredes F, Fontecilla T, Jara G, Pizarro A, Acevedo J, Leo K, Leon F, et al. Effectiveness of an Inactivated SARS-CoV-2 vaccine in Chile. NEJM. 2021;385(10):875–84.doi:https://doi.org/10.1056/NEJMoa2107715.
- Gao C, Cai Y, Zhang K, Zhou L, Zhang Y, Zhang X, Li Q, Li W, Yang S, Zhao X, et al. Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study. Eur Heart J. 2020;41(22):2058–66.doi:https://doi.org/10.1093/eurheartj/ehaa433.
- Iaccarino G, Grassi G, Borghi C, Ferri C, Salvetti M, Volpe Massimo M, Cicero AFG, Minuz P, Muiesan ML, Mulatero P. Age and multimorbidity predict death among COVID-19 Patients: results of the SARS-RAS study of the Italian society of hypertension. Hypertension. 2020;76(2):1372–79.doi:https://doi.org/10.1161/HYPERTENSIONAHA.120.15324.
- Du Y, Tu L, Zhu P, Mu M, Wang R, Yang P, Wang X, Hu C, Ping R, Hu P, et al. Clinical features of 85 fatal cases of COVID-19 from Wuhan: a retrospective observational study. Am J Respir Crit Care Med. 2020;201(11):1372–79.doi:https://doi.org/10.1164/rccm.202003-0543OC.
- Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, Shi J, Zhou M, Wu B, Yang Z, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110.doi:https://doi.org/10.1016/j.jaci.2020.04.006.
- Trougakos IP, Terpos E, Zirou C, Sklirou AD, Apostolakou F, Gumeni S, Charitaki I, Papanagnou E-D, Bagratuni T, Liacos C-I, et al. Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients. BMC Med. 2021;19(1):208.doi:https://doi.org/10.1186/s12916-021-02090-6.
- Li M, Yang J, Wang L, Wu Q, Wu Z, Zheng W, et al. A booster dose is immunogenic and will be needed for older adults who have completed two doses vaccination with CoronaVac: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. medRxiv. 2021. Aug.03;21261544.
- Pan H, Wu Q, Zeng G, Yang J, Jiang D, Deng X, et al. Immunogenicity and safety of a third dose, and immune persistence of CoronaVac vaccine in healthy adults aged 18-59 years: interim results from a double-blind, randomized, placebo-controlled phase 2 clinical trial. medRxiv. 2021. July 2021 2021.Jul.23;21261026.
- Inoue T, Moran I, Shinnakasu R, Phan TG, Kurosaki T. Generation of memory B cells and their reactivation. Immunol Rev. 2018;283(1):138–49.doi:https://doi.org/10.1111/imr.12640.
- Ji Q, Cheng G, Ma N, Huang Y, Lin Y, Zhou Q, Que B, Dong J, Zhou Y, Nie S, et al. Circulating Th1, Th2, and Th17 levels in hypertensive patients. Dis Markers. 2017;2017:7146290.
- Asadikaram G, Ram M, Izadi A, Sheikh Fathollahi M, Nematollahi MH, Najafipour H, Shahoozehi B, Mirhoseini M, Masoumi M, Shahrokhi N, et al. The study of the serum level of IL-4, TGF-β, IFN-γ, and IL-6 in overweight patients with and without diabetes mellitus and hypertension. J Cell Biochem. 2019;120(3):4147–57.doi:https://doi.org/10.1002/jcb.27700.
- Mikolajczyk TP, Guzik TJ. Adaptive Immunity in Hypertension. Curr Hypertens Rep. 2019;21(9):68.doi:https://doi.org/10.1007/s11906-019-0971-6.
- Shao J, Nangaku M, Miyata T, Inagi R, Yamada K, Kurokawa K, Fujita T. Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension. 2003 Jul;42(1):31–38. doi:https://doi.org/10.1161/01.HYP.0000075082.06183.4E.
- Nakamura K, Fuster JJ, Walsh K. Adipokines: a link between obesity and cardiovascular disease. J Cardiol. 2014;63(4):250–59.doi:https://doi.org/10.1016/j.jjcc.2013.11.006.